Skip to main content
Top
Published in: Knee Surgery, Sports Traumatology, Arthroscopy 11/2016

01-11-2016 | Knee

Will a single periarticular lidocaine–corticosteroid injection improve the clinical efficacy of intraarticular hyaluronic acid treatment of symptomatic knee osteoarthritis?

Authors: Cemil Ertürk, Mehmet Akif Altay, Nuray Altay, Ali Murat Kalender, İbrahim Avşin Öztürk

Published in: Knee Surgery, Sports Traumatology, Arthroscopy | Issue 11/2016

Login to get access

Abstract

Purpose

A local injection of corticosteroid–lidocaine into the periarticular soft tissue structures is used commonly for rapid pain relief. It is hypothesized that knee pain associated with knee osteoarthritis would be relieved quickly and effectively in patients receiving intraarticular hyaluronic acid combined with a periarticular lidocaine–corticosteroid injection. To test this hypothesis, the clinical effect of the combined treatment with hyaluronic acid injection alone in patients with symptomatic knee osteoarthritis as compared in this prospective single-blinded randomized trial.

Methods

This study included 70 patients. Group 1 (n = 35) received intraarticular hyaluronic acid injections only, whereas group 2 (n = 35) received intraarticular hyaluronic acid injections combined with a single local injection of corticosteroid–lidocaine. Injections were administered to the most painful areas of the anterior or posterior medial condyle of the femur or tibia. The outcome was measured by independent assessors (blinded to treatment) using a linear VAS pain scale and WOMAC and HSS knee scores. Assessments were performed at baseline and at 1, 3, 6, 12, 26, and 52 weeks.

Results

During the first 3 weeks, group 2 patients showed significantly better all scores than did group 1 patients (p < 0.01). However, no significant differences were detected at 6, 12, 26 or 52 weeks (n.s.).

Conclusion

The combined treatment may lead to earlier pain relief compared with intraarticular hyaluronic acid alone in patients with knee osteoarthritis and can be considered a useful adjunctive treatment modality. This combined method may provide early return to patient’s daily activity.

Level of evidence

Therapeutic study, Level I.
Literature
1.
go back to reference Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049CrossRefPubMed Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049CrossRefPubMed
2.
go back to reference Altman RD, Rosen JE, Bloch DA et al (2009) A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum 39:1–9CrossRefPubMed Altman RD, Rosen JE, Bloch DA et al (2009) A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum 39:1–9CrossRefPubMed
3.
go back to reference Alvarez-Nemegyei J (2007) Risk factors for pes anserinus tendinitis/bursitis syndrome: a case control study. J Clin Rheumatol 13:63–65CrossRefPubMed Alvarez-Nemegyei J (2007) Risk factors for pes anserinus tendinitis/bursitis syndrome: a case control study. J Clin Rheumatol 13:63–65CrossRefPubMed
4.
go back to reference Axe JM, Snyder-Mackler L, Axe MJ (2013) The role of viscosupplementation. Sports Med Arthrosc 21(1):18–22CrossRefPubMed Axe JM, Snyder-Mackler L, Axe MJ (2013) The role of viscosupplementation. Sports Med Arthrosc 21(1):18–22CrossRefPubMed
5.
go back to reference Bannuru RR, Natov NS, Obadan IE et al (2009) Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 61(12):1704–1711CrossRefPubMed Bannuru RR, Natov NS, Obadan IE et al (2009) Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 61(12):1704–1711CrossRefPubMed
6.
go back to reference Bannuru RR, Vaysbrot EE, Sullivan MC et al (2014) Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 43(5):593–599CrossRefPubMed Bannuru RR, Vaysbrot EE, Sullivan MC et al (2014) Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 43(5):593–599CrossRefPubMed
7.
go back to reference Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed
8.
go back to reference Bellamy N, Campbell J, Robinson V et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 19:(2):CD005321 Bellamy N, Campbell J, Robinson V et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 19:(2):CD005321
9.
go back to reference Brandt KD (2011) Why should we expect a structure-modifying osteoarthritis drug to relieve osteoarthritis pain? Ann Rheum Dis 70:1175–1177CrossRefPubMed Brandt KD (2011) Why should we expect a structure-modifying osteoarthritis drug to relieve osteoarthritis pain? Ann Rheum Dis 70:1175–1177CrossRefPubMed
10.
go back to reference Chou CW, Lue KH, Lee HS (2009) Hylan G-F 20 has better pain relief and cost-effectiveness than sodium hyaluronate in treating early osteoarthritic knees in Taiwan. J Formos Med Assoc 108:663–672CrossRefPubMed Chou CW, Lue KH, Lee HS (2009) Hylan G-F 20 has better pain relief and cost-effectiveness than sodium hyaluronate in treating early osteoarthritic knees in Taiwan. J Formos Med Assoc 108:663–672CrossRefPubMed
11.
go back to reference Collins NJ, Bierma-Zeinstra SM, Crossley KM et al (2013) Prognostic factors for patellofemoral pain: a multicentre observational analysis. Br J Sports Med 47(4):227–233CrossRefPubMed Collins NJ, Bierma-Zeinstra SM, Crossley KM et al (2013) Prognostic factors for patellofemoral pain: a multicentre observational analysis. Br J Sports Med 47(4):227–233CrossRefPubMed
13.
go back to reference de Campos GC, Rezende MU, Pailo AF et al (2013) Adding triamcinolone improves viscosupplementation: a randomized clinical trial. Clin Orthop Relat Res 471(2):613–620CrossRefPubMed de Campos GC, Rezende MU, Pailo AF et al (2013) Adding triamcinolone improves viscosupplementation: a randomized clinical trial. Clin Orthop Relat Res 471(2):613–620CrossRefPubMed
14.
go back to reference Folman Y, Shabat S (2011) Local treatment of a painful knee with cortiscosteroids: the efficacy of intra-articular injection compared with peri-articular soft tissue infiltration. J Musculoskelet Pain 19:154–157CrossRef Folman Y, Shabat S (2011) Local treatment of a painful knee with cortiscosteroids: the efficacy of intra-articular injection compared with peri-articular soft tissue infiltration. J Musculoskelet Pain 19:154–157CrossRef
15.
go back to reference Gigante A, Callegari L (2011) The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis. Rheumatol Int 31(4):427–444CrossRefPubMed Gigante A, Callegari L (2011) The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis. Rheumatol Int 31(4):427–444CrossRefPubMed
16.
go back to reference Gomoll AH, Kang RW, Williams JM et al (2006) Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder. Arthroscopy 22:813–819CrossRefPubMed Gomoll AH, Kang RW, Williams JM et al (2006) Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder. Arthroscopy 22:813–819CrossRefPubMed
18.
go back to reference Housman L, Arden N, Schnitzer TJ et al (2014) Intra-articular hylastan versus steroid for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 22(7):1684–1692CrossRefPubMed Housman L, Arden N, Schnitzer TJ et al (2014) Intra-articular hylastan versus steroid for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 22(7):1684–1692CrossRefPubMed
19.
go back to reference Iannitti T, Lodi D, Palmieri B (2011) Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid. Drugs R D11:13–27CrossRef Iannitti T, Lodi D, Palmieri B (2011) Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid. Drugs R D11:13–27CrossRef
20.
21.
go back to reference Insall JN, Ranawat CS, Aglietti P et al (1976) A comparison of four models of total knee-replacement prostheses. J Bone Joint Surg Am 58:754–765CrossRefPubMed Insall JN, Ranawat CS, Aglietti P et al (1976) A comparison of four models of total knee-replacement prostheses. J Bone Joint Surg Am 58:754–765CrossRefPubMed
22.
go back to reference Jørgensen A, Stengaard-Pedersen K, Simonsen O et al (2010) Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis 69:1097–1102CrossRefPubMed Jørgensen A, Stengaard-Pedersen K, Simonsen O et al (2010) Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis 69:1097–1102CrossRefPubMed
23.
go back to reference Karatosun V, Unver B, Gocen Z (2006) Intra-articular hyaluranic acid compared with progressive knee exercises in osteoarthritis of the knee: a prospective randomized trial with long-term follow-up. Rheumatol Int 26:277–284CrossRefPubMed Karatosun V, Unver B, Gocen Z (2006) Intra-articular hyaluranic acid compared with progressive knee exercises in osteoarthritis of the knee: a prospective randomized trial with long-term follow-up. Rheumatol Int 26:277–284CrossRefPubMed
24.
go back to reference Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheumatol Dis 16:494–502CrossRef Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheumatol Dis 16:494–502CrossRef
25.
go back to reference Leighton R, Akermark C, Therrien R et al (2014) NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthr Cartil 22(1):17–25CrossRefPubMed Leighton R, Akermark C, Therrien R et al (2014) NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthr Cartil 22(1):17–25CrossRefPubMed
26.
go back to reference Leopold SS, Redd BB, Warme WJ (2003) Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am 85A:1197–1203CrossRef Leopold SS, Redd BB, Warme WJ (2003) Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am 85A:1197–1203CrossRef
27.
go back to reference Lirk P, Picardi S, Hollmann MW (2014) Local anaesthetics: 10 essentials. Eur J Anaesthesiol 31:1–11CrossRef Lirk P, Picardi S, Hollmann MW (2014) Local anaesthetics: 10 essentials. Eur J Anaesthesiol 31:1–11CrossRef
28.
go back to reference Liu L, Liu Y, Li J (2011) Microbial production of hyaluronic acid: current state, challenges, and perspectives. Microb Cell Fact 16(10):99CrossRef Liu L, Liu Y, Li J (2011) Microbial production of hyaluronic acid: current state, challenges, and perspectives. Microb Cell Fact 16(10):99CrossRef
29.
go back to reference Nichols AW (2005) Complications associated with the use of corticosteroids in the treatment of athletic injuries. Clin J Sport Med 15(5):370–375CrossRefPubMed Nichols AW (2005) Complications associated with the use of corticosteroids in the treatment of athletic injuries. Clin J Sport Med 15(5):370–375CrossRefPubMed
30.
go back to reference Ozturk C, Atamaz F, Hepguler S (2006) The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study. Rheumatol Int 26:314–319CrossRefPubMed Ozturk C, Atamaz F, Hepguler S (2006) The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study. Rheumatol Int 26:314–319CrossRefPubMed
31.
go back to reference Papacrhistou G, Anagnostou S, Katsorhis T (1997) The effect of intraarticular hydrocortisone injection on the articular cartilage of rabbits. Acta Orthop Scand Suppl 275:132–134CrossRefPubMed Papacrhistou G, Anagnostou S, Katsorhis T (1997) The effect of intraarticular hydrocortisone injection on the articular cartilage of rabbits. Acta Orthop Scand Suppl 275:132–134CrossRefPubMed
32.
go back to reference Raman R, Dutta A, Day N (2008) Efficacy of hylan G-F 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee—a prospective randomized clinical trial. Knee 15:318–324CrossRefPubMed Raman R, Dutta A, Day N (2008) Efficacy of hylan G-F 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee—a prospective randomized clinical trial. Knee 15:318–324CrossRefPubMed
33.
go back to reference Scott NA, Guo B, Barton PM (2009) Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med 10:54–69CrossRefPubMed Scott NA, Guo B, Barton PM (2009) Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med 10:54–69CrossRefPubMed
34.
go back to reference Simons DG (2004) Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J Electromyogr Kinesiol 14:95–107CrossRefPubMed Simons DG (2004) Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J Electromyogr Kinesiol 14:95–107CrossRefPubMed
35.
go back to reference Stephens MB, Beutler AI, O’Connor FG (2008) Musculoskeletal injections: a review of the evidence. Am Fam Physician 78(8):971–976PubMed Stephens MB, Beutler AI, O’Connor FG (2008) Musculoskeletal injections: a review of the evidence. Am Fam Physician 78(8):971–976PubMed
36.
go back to reference Uson J, Aguado P, Bernad M (2000) Pes anserinus tendino-bursitis: what are we talking about? Scand J Rheumatol 29:184–186CrossRefPubMed Uson J, Aguado P, Bernad M (2000) Pes anserinus tendino-bursitis: what are we talking about? Scand J Rheumatol 29:184–186CrossRefPubMed
37.
go back to reference Wang CT, Lin J, Chang CJ (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86A:538–545CrossRef Wang CT, Lin J, Chang CJ (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86A:538–545CrossRef
38.
go back to reference Yentür EA, Okçu G, Yegül I (2004) The role of trigger point therapy in knee osteoarthritis. The Pain Clinic 15:385–390CrossRef Yentür EA, Okçu G, Yegül I (2004) The role of trigger point therapy in knee osteoarthritis. The Pain Clinic 15:385–390CrossRef
39.
go back to reference Yoon HS, Kim SE, Suh YR (2005) Correlation between ultrasonographic findings and the response to corticosteroid injection in pes anserinus tendinobursitis syndrome in knee osteoarthritis patients. J Korean Med Sci 20:109–112CrossRefPubMedPubMedCentral Yoon HS, Kim SE, Suh YR (2005) Correlation between ultrasonographic findings and the response to corticosteroid injection in pes anserinus tendinobursitis syndrome in knee osteoarthritis patients. J Korean Med Sci 20:109–112CrossRefPubMedPubMedCentral
40.
go back to reference Zhang W, Moskowitz RW, Nuki G et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16(2):137–162CrossRefPubMed Zhang W, Moskowitz RW, Nuki G et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16(2):137–162CrossRefPubMed
Metadata
Title
Will a single periarticular lidocaine–corticosteroid injection improve the clinical efficacy of intraarticular hyaluronic acid treatment of symptomatic knee osteoarthritis?
Authors
Cemil Ertürk
Mehmet Akif Altay
Nuray Altay
Ali Murat Kalender
İbrahim Avşin Öztürk
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Knee Surgery, Sports Traumatology, Arthroscopy / Issue 11/2016
Print ISSN: 0942-2056
Electronic ISSN: 1433-7347
DOI
https://doi.org/10.1007/s00167-014-3398-2

Other articles of this Issue 11/2016

Knee Surgery, Sports Traumatology, Arthroscopy 11/2016 Go to the issue